KESIMPTA

Google image searchProduct monograph

Active ingredient

ofatumumab, 20 MG/0.4 ML

DIN: 02511355

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: PRE-FILLED PEN

Schedule: Prescription / Schedule D

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 08-APR-2021

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AG — Monoclonal antibodies (ATC, ATC/DDD)
• L04AG12 — OFATUMUMAB (ATC/DDD)

Reference brand drug: Arzerra

External Links for Kesimpta

Search on Google

• Kesimpta side effects
• Kesimpta dosage
• ofatumumab side effects
• ofatumumab dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find kesimpta photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.